Incidence and characteristics of antiandrogen withdrawal syndrome in prostate cancer after treatment with chlormadinone acetateAKAKURA, K; AKIMOTO, S; FURUYA, Y et al.European urology. 1998, Vol 33, Num 6, pp 567-571, issn 0302-2838Article

Prognosis of patients with prostate carcinoma presenting as non regional lymph node metastasesFURUYA, Y; AKAKURA, K; AKIMOTO, S et al.Urologia Internationalis. 1998, Vol 61, Num 1, pp 17-21, issn 0042-1138Article

Pain caused by bone metastasis in endocrine-therapy-refractory prostate cancerAKAKURA, K; AKIMOTO, S; SHIMAZAKI, J et al.Journal of cancer research and clinical oncology. 1996, Vol 122, Num 10, pp 633-637, issn 0171-5216Article

Tumor marker doubling time in patients with prostate cancer : determination of prostate-specific antigen and prostatic acid phosphatase doubling timeAKIMOTO, S; MASAI, M; AKAKURA, K et al.European urology. 1995, Vol 27, Num 3, pp 207-212, issn 0302-2838Article

Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis : Comparison with the extent of disease (EOD) gradeAKIMOTO, S; FURUYA, Y; AKAKURA, K et al.The Prostate. 1999, Vol 38, Num 1, pp 28-34, issn 0270-4137Article

A novel missense mutation of SLC7A9 frequent in Japanese cystinuria cases affecting the C-terminus of the transporterSHIGETA, Y; KANAI, Y; UEDA, T et al.Kidney international. 2006, Vol 69, Num 7, pp 1198-1206, issn 0085-2538, 9 p.Article

Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinomaTAKEDA, H; AKAKURA, K; MASAI, M et al.Cancer. 1996, Vol 77, Num 5, pp 934-940, issn 0008-543XArticle

Effect of tumour progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinomaRENNIE, P. S; BRUCHOVSKY, N; AKAKURA, K et al.Journal of steroid biochemistry and molecular biology. 1994, Vol 50, Num 1-2, pp 31-40, issn 0960-0760Article

Identification of five novel SLC3A1 (rBAT) gene mutations in Japanese cystinuriaEGOSHI, K.-I; AKAKURA, K; KODAMA, T et al.Kidney international. 2000, Vol 57, Num 1, pp 25-32, issn 0085-2538Article

Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer : Radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalitiesAKAKURA, K; ISAKA, S; TOBISU, K.-I et al.Urology (Ridgewood, NJ). 1999, Vol 54, Num 2, pp 313-318, issn 0090-4295Article

Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinomaAKAKURA, K; BRUCHOVSKY, N; RENNIE, P. S et al.Journal of steroid biochemistry and molecular biology. 1996, Vol 59, Num 5-6, pp 501-511, issn 0960-0760Article

Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancerUEDA, T; ICHIKAWA, T; ITO, H et al.The American journal of pathology. 1996, Vol 149, Num 5, pp 1435-1440, issn 0002-9440Conference Paper

Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate. Commentary. Authors' replyAKAKURA, K; AKIMOTO, S; OHKI, T et al.Urology (Ridgewood, NJ). 1995, Vol 45, Num 4, pp 700-705, issn 0090-4295Article

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeksNOMIYA, T; TSUJI, H; MARUYAMA, K et al.British journal of cancer. 2014, Vol 110, Num 10, pp 2389-2395, issn 0007-0920, 7 p.Article

Laparoscopic adrenalectomy for functioning adrenal tumors : clinical experiences with 38 cases and comparison with open adrenalectomyICHIKAWA, T; MIKAMI, K; KOMIYA, A et al.Biomedicine & pharmacotherapy. 2000, Vol 54, pp 178s-182s, issn 0753-3322, SUP1Article

The long-term outcome of cystinuria in JapanAKAKURA, K; EGOSHI, K; UEDA, T et al.Urologia Internationalis. 1998, Vol 61, Num 2, pp 86-89, issn 0042-1138Article

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer : Relation to antiandrogen withdrawal syndromeSUZUKI, H; AKAKURA, K; KOMIYA, A et al.The Prostate. 1996, Vol 29, Num 3, pp 153-158, issn 0270-4137Article

Characterization of 5α-reductase gene expression in stroma and epithelium of human prostateBRUCHOVSKY, N; SADAR, M. D; AKAKURA, K et al.Journal of steroid biochemistry and molecular biology. 1996, Vol 59, Num 5-6, pp 397-404, issn 0960-0760Article

Control of tumor progression by maintenance of apoptosisBRUCHOVSKY, N; SNOEK, R; RENNIE, P. S et al.The Prostate. 1996, pp 13-21, issn 0270-4137, SUP6Conference Paper

Response of prostate-specific antigen after androgen withdrawal and prognosis in men with metastatic prostate cancerFURUYA, Y; AKIMOTO, S; AKAKURA, K et al.Urologia Internationalis. 1998, Vol 60, Num 1, pp 28-32, issn 0042-1138Article

Intermittent androgen suppression in the treatment of prostate cancer : a preliminary report. CommentaryGOLDENBERG, S. L; BRUCHOVSKY, N; GLEAVE, M. E et al.Urology (Ridgewood, NJ). 1995, Vol 45, Num 5, pp 839-845, issn 0090-4295Article

Chemotherapy for endocrine-therapy-refractory prostate cancerAKIMOTO, S; OHKI, T; AKAKURA, K et al.Cancer chemotherapy and pharmacology. 1994, Vol 35, pp S18-S22, issn 0344-5704, SUPConference Paper

Effects of intermittent androgen suppression on androgen-dependent tumors : apoptosis and serum prostate-specific antigenAKAKURA, K; BRUCHOVSKY, N; GOLDENBERG, S. L et al.Cancer. 1993, Vol 71, Num 9, pp 2782-2790, issn 0008-543XArticle

Acquired expression of hst-1 in an autonomous subline (Chiba subline 2) derived from androgen-responsive mouse mammary tumor (Shionogi carcinoma 115)AKAKURA, K; FURUYA, Y; SATO, N et al.Japanese journal of cancer research. 1990, Vol 81, Num 6-7, pp 554-556, issn 0910-5050Article

Clinical significance of nonpalpable prostate cancer with favorable biopsy features in Japanese menKAKEHI, Y; KAMOTO, T; SUMIYOSHI, Y et al.European urology. 2000, Vol 37, Num 5, pp 552-558, issn 0302-2838Article